Is It Time to Revamp the Drug Development Pipeline?

 

Keypoints:

  • Pharmaceutical industry is under pressure to increase demand and productivity.
  • Pharma manufacturers are also expected to reduce waste in the drug development pipeline.
  • Translational research is to get an idea to translate in a way to benefit the patient.

Commentary:

The pharmaceutical industry is undergoing a series of rapid changes. These days, there is higher demand, increased productivity, a race to get the drugs into consumers’ hands at a record pace, and a push to minimize waste in the process. MarketScale talked to Dr. Gabi Hanna, the CEO of Lamassu Pharma, to give his take on the drug development pipeline and what needs to be updated once the drug hits the market.

Abridged Thoughts:

In a basic and simple way, translational research is to take the idea from research and how to translate it into a tangible way to benefit the patient. This is the translation of knowledge to make a real impact on a patient. That is basically, in a nutshell, what does translational research is for us. 

More Like This Story:

What Can the Pharma Industry Learn from Merck’s New Antiviral?

MarketScale sourced Dr. Kishor M. Wasan, Chief Medical and Scientific Officer at Skymount Medical, for his perspective, pulling from his active research around drug production and AI. Scroll down for his various insights!

What is Behind the “Mergers & Acquisitions” Boom in Healthcare?

As the country continues to open and up and start on that path to recovery there has been a recent boom of healthcare mergers and acquisitions. On this upcoming episode of I Don’t Care, Kevin Stevenson speaks with the Co-Founders and Partners of M&A Healthcare Advisors, a boutique advisor firm whose focus is on the healthcare industry. The group talks about their plans to help small to middle sized businesses with M&As and how they hope to work with companies hands-on.

Follow us on social media for the latest updates in B2B!

Image

Latest

retail
Transforming Retail Resilience with Contract Intelligence
April 30, 2025

In the fast-moving world of retail, success hinges on delivering the right products to the right places at the right time—an endeavor powered by complex networks of contracts. Yet, many retail, consumer goods, and distribution companies still rely on outdated, manual approaches to contract management that slow innovation and create unnecessary risk. Icertis is changing…

Read More
CFO Roundtable
Driving Financial Transformation: Insights from the Icertis CFO Roundtable
April 30, 2025

In today’s dynamic business climate, the role of the CFO extends far beyond traditional finance—it’s now central to steering enterprise-wide transformation. At Icertis, the CFO Roundtable serves as a powerful forum where financial leaders gather to explore how digital technologies, particularly contract intelligence, are reshaping risk management, compliance, and growth strategies. This roundtable isn’t just…

Read More
contract intelligence
Refounding the Future: How Icertis Is Redefining Contract Intelligence and Commerce
April 29, 2025

In today’s evolving digital economy, the core of transformation lies not in technology alone, but in the relationships that shape commerce. As companies race to become more agile and purpose-driven, redefining the role of contracts—from static legal documents to dynamic assets—becomes essential. Icertis stands at the forefront of this change, not only offering contract intelligence,…

Read More
boots on the ground
Boots on the Ground: Supporting Veterans at Icertis
April 29, 2025

For many veterans, the journey home is just the beginning of another battle—one that involves finding purpose, connection, and opportunity in civilian life. The transition from military service to the corporate world is often filled with unseen barriers, from translating service roles into civilian job language to navigating workplace cultures that don’t always understand the…

Read More